BioStock: Iconovo makes progress in the outlicensing process for ICOpre

Iconovo is approaching the out-licensing of the inhaler ICOpre by now actively seeking contact with potential partners. The company is collaborating with investment bank Stifel to maximise business value and several international pharmaceutical companies have already expressed interest through confidential disclosure agreements. 

Read the full article at biostock.se:

https://www.biostock.se/en/2023/09/iconovo-makes-progress-in-the-outlicensing-process-for-icopre/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se